Rising Orthopedic Procedures Propel Growth in the Sciatica Market: Strengthening the Growth Trajectory of the Sciatica Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

What Is the Expected CAGR for the Sciatica Market Through 2025?
Lately, the market size for sciatica has demonstrated robust growth. It is predicted to escalate from $6.93 billion in 2024 to $7.35 billion in 2025, with a compound annual growth rate (CAGR) of 6.0%. The remarkable expansion in the historical period is credited to advancements in pain management treatments, digital health, telemedicine, tailored treatment strategies, and integrative care models.

What's the Projected Size of the Global Sciatica Market by 2029?
Over the coming years, the market size of sciatica is projected to experience substantial growth, expanding to $9.14 billion in 2029 with a compound annual growth rate (CAGR) of 5.6%. Factors contributing to this future growth encompass personalized medicine, the evolution of telemedicine and remote procedures, enhanced patient education and awareness, as well as developed reimbursement policies. Key trends anticipated during the forecast period incorporate advanced diagnostic imaging, emerging regenerative medicine, digital therapeutics technologies and preventative actions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/sciatica-global-market-report

Top Growth Drivers in the Sciatica Industry: What's Accelerating the Market?
The growth of the sciatica market is expected to be propelled by the increasing instances of orthopedic procedures. Usually, orthopedic procedures are surgeries designed to manage conditions that impact the spine, joints, and to rectify skeletal irregularities. Factors such as an elderly population, increasing rates of musculoskeletal disorders, and more participation in physical activities and sports contribute to the rise in orthopedic procedures. Treatment for sciatica offers enhanced pain alleviation, re-establishes mobility and function, and thus enhances life quality for sciatica patients. Orthopedic practitioners and surgeons typically participate in diagnosing and treating sciatica. For example, research published by the National Library of Medicine, a biomedical library based in the U.S., predicted in February 2023 that the number of total hip arthroplasty (THA) and total knee arthroplasty (TKA) procedures would rise by 719,364 and 1,222,988 respectively by 2040. Moreover, it is projected that by 2060, TKAs will reach a total of 2,917,959 while THAs are expected to sum up to 1,982,099. Thus, the rising number of orthopedic procedures is a driving factor for the growth of the sciatica market. The sciatica market's expansion is also anticipated to be driven by the increasing occurrence of back problems. Problems with the back usually refer to any mechanical or structural complications arising from the spine, discs, muscles, ligaments, or tendons' back, or anything that compresses the nerves in the back. The surge in back problems can lead to an increase in the sciatica market since individuals with back problems are more prone to developing sciatica. Consequently, there is an increased demand for products and services providing relief from sciatica pain. For instance, an analysis reflecting over 30 years of data by the University of Sidney, a government agency based in Australia, showed an increasing number of cases with low back pain in May 2023. Their modeling suggests that due to population growth and ageing, around 843 million people will be affected by this condition by 2050. Hence, the increasing prevalence of back issues is a key driver for the growth of the sciatica market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13000&type=smp

What Trends Will Shape the Sciatica Market Through 2029 and Beyond?
Leading firms in the sciatica market are venturing into product innovation and securing approval from governmental bodies to remain competitive. The innovation in sciatica treatment offers improved treatment options, lessens side effects, augments efficiency, and broadens the treatment spectrum. For example, in June 2022, SciatiEase Labs, a health supplement company based in the US, received approval for its product, SciatiEase, from the United States Food and Drug Administration (FDA). SciatiEase is a powerful supplement that fuses several beneficial ingredients into a single pill, designed to alleviate the occasional discomfort caused by sciatic nerve pain. Furthermore, these supplements are tailored for people who regularly suffer discomfort along the sciatic nerve and are unable to consume foods that may naturally soothe the pain from the sciatic nerve.

What Are the Main Segments in the Sciatica Market?
The sciatica market covered in this report is segmented -

1) By Type: Acute Sciatica, Chronic Sciatica, Other Types
2) By Drugs: Oxycodone, trama*dol, Opioid Analgesics, Amitriptyline, Tricyclic Antidepressants, Other Drugs
3) By Treatment: Medication, Surgery
4) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:
1) By Acute Sciatica: Short-Term Pain Management, Physical Therapy, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
2) By Chronic Sciatica: Long-Term Pain Management, Epidural Steroid Injections, Surgical Options
3) By Other Types: Sciatica Due To Herniated Disc, Sciatica From Spinal Stenosis, Sciatica From Spondylolisthesis

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13000&type=smp

Which Top Companies are Driving Growth in the Sciatica Market?
Major companies operating in the sciatica market are Pfizer Inc., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Macleods Pharmaceuticals Limited, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Ltd., Intas Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Endo International PLC, Amneal Pharmaceuticals Inc., Aspen Pharmacare Holdings Limited, Zydus Lifesciences Ltd., Lupin Limited, Alkem Laboratories Limited, Torrent Pharmaceuticals Ltd.

Which Regions Will Dominate the Sciatica Market Through 2029?
North America was the largest region in the sciatica market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sciatica market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13000

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.